Skip to content

ChanGes In Right ventricular volumes And Function Following diurEtic Treatment In Pulmonary arterial hypertension patients with decompensated right heart failure (GIRAFFE)

ChanGes In Right ventricular volumes And Function Following diurEtic Treatment In Pulmonary arterial hypertension patients with decompensated right heart failure (GIRAFFE) - Changes in right ventricular volumes and function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44204
Enrollment
34
Registered
2017-11-14
Start date
2018-02-27
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertension right heart failure

Interventions

None listed

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of idiopathic PAH, hereditary PAH, drug- and toxins induced PAH or chronic thrombo-embolic PH (CTEPH), according to ESC/ERS pulmonary hypertension guidelines (15) - Symptoms of decompensated right heart failure (ankle edema, ascites, weight gain) based on the assessment and the evaluation of the pulmonologist for which an up-titration of the diuretics is indicated - Age >=18 and

Exclusion criteria

Exclusion criteria: - Pregnant subjects - Claustrophobia - Inability to provide informed consent - Change in PAH specific therapy during or the 3 months before the up-titration of diuretics - Change in (dose) of any other medication. - One or more of the following co-morbidities:, uncontrolled systemic hypertension (>140/90 mmHg) , renal failure (eGFR

Design outcomes

Primary

MeasureTime frame
Change in stroke volume (SV) , Change in right ventricular ejection fraction (RVEF) (%), Change in right ventricular end diastolic volume (RVEDV) (ml), Change in right ventricular end systolic volume (RVESV) (ml), Change in right atrial pressure (RAP),volume, Change in right ventricular strain.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)